NCT01993927View on ClinicalTrials.gov

"Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance Long-term Use in Patients With Impaired Glucose Tolerance"

CompletedOBSERVATIONAL
Enrollment

742

Participants

Timeline

Start Date

November 18, 2009

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Impaired Glucose Tolerance
Interventions
DRUG

Voglibose

Voglibose Tablets / Voglibose OD Tablets

Trial Locations (1)

Unknown

Osaka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY